sur Cynosure Lutronic
Cynosure Lutronic Expands Global Reach with Mosaic 3D™ Approval
Cynosure Lutronic has announced that its Mosaic 3D™ platform has achieved CE Mark approval under the European MDR, advancing its global expansion strategy. Mosaic 3D™, a non-ablative fractional laser system, is designed to enhance energy delivery while maintaining patient comfort and safety. Its approval signifies a vital milestone for the company.
The device features 3D Controlled Chaos Technology™ and an integrated cooling system, which optimize treatment outcomes and reduce patient discomfort. It has been lauded for its versatility in enhancing skin revitalization. Key opinion leaders such as Dr. Guy Erlich and Prof. Merete Haedersdal have validated its effectiveness in clinical settings.
Mosaic 3D™ will be featured prominently at the 2026 IMCAS World Congress, with a dedicated symposium to highlight its capabilities. The company remains consistent in pushing the boundaries of medical aesthetics by focusing on evidence-based innovation.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Cynosure Lutronic